Literature DB >> 1873720

Epidemiology of chronic venous ulcers.

S R Baker1, M C Stacey, A G Jopp-McKay, S E Hoskin, P J Thompson.   

Abstract

A metropolitan population of 238,000 in Perth, Western Australia, was screened for chronic ulceration of the leg. Patients with a chronic leg ulcer and a venous abnormality comprised 57 per cent of all patients with a chronic leg ulcer, giving a prevalence of 0.62 per 1000 population. There was an increasing prevalence with age; 90 per cent of patients were 60 years and older. This group comprised 16.7 per cent of the population, and had a prevalence of 3.3 per 1000. Although chronic venous ulcers were more common in women there was no difference in age related prevalence. In 36 per cent of patients with a venous abnormality, there was at least one other aetiological factor contributing to chronic ulceration of the leg; 96 per cent had either a history of deep venous thrombosis or a condition known to predispose to deep venous thrombosis.

Entities:  

Mesh:

Year:  1991        PMID: 1873720     DOI: 10.1002/bjs.1800780729

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  47 in total

1.  Measurement of forces associated with compression therapy.

Authors:  D Wertheim; J Melhuish; R Williams; K Harding
Journal:  Med Biol Eng Comput       Date:  1999-01       Impact factor: 2.602

Review 2.  Leg ulceration in venous disease.

Authors:  S K Shami; D A Shields; J H Scurr; P D Smith
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

3.  The impact of providing product funding for compression bandaging and medical footwear on compression use, wound healing and quality of life.

Authors:  Suzanne Kapp; Charne Miller; Kylie Elder
Journal:  Int Wound J       Date:  2011-12-16       Impact factor: 3.315

4.  The financial and quality-of-life cost to patients living with a chronic wound in the community.

Authors:  Suzanne Kapp; Nick Santamaria
Journal:  Int Wound J       Date:  2017-06-20       Impact factor: 3.315

5.  A prospective, multi-centre, randomised, open label, parallel, comparative study to evaluate effects of AQUACEL® Ag and Urgotul® Silver dressing on healing of chronic venous leg ulcers.

Authors:  Keith Harding; Finn Gottrup; Arkadiusz Jawień; Jacek Mikosiński; Krystyna Twardowska-Saucha; Sławomir Kaczmarek; Maciej Sopata; Cliff Shearman; Alaine Pieronne; Dheerendra Kommala
Journal:  Int Wound J       Date:  2011-11-09       Impact factor: 3.315

6.  Definition of infection in chronic wounds by Dutch nursing home physicians.

Authors:  A A L M Rondas; J M G A Schols; E E Stobberingh; P E Price
Journal:  Int Wound J       Date:  2009-08       Impact factor: 3.315

Review 7.  Preventing venous ulcer recurrence: a review.

Authors:  Kathryn R Vowden; Peter Vowden
Journal:  Int Wound J       Date:  2006-03       Impact factor: 3.315

8.  Measuring costs and quality of life for venous leg ulcers.

Authors:  Louise Barnsbee; Qinglu Cheng; Ruth Tulleners; Xing Lee; David Brain; Rosana Pacella
Journal:  Int Wound J       Date:  2018-10-05       Impact factor: 3.315

9.  Effectiveness of prostaglandin E1 in patients with mixed arterial and venous ulcers of the lower limbs.

Authors:  Giovanni De Caridi; Mafalda Massara; Francesco Stilo; Francesco Spinelli; Raffaele Grande; Lucia Butrico; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2014-08-05       Impact factor: 3.315

10.  Chronic venous disease in an ethnically diverse population: the San Diego Population Study.

Authors:  Michael H Criqui; Maritess Jamosmos; Arnost Fronek; Julie O Denenberg; Robert D Langer; John Bergan; Beatrice A Golomb
Journal:  Am J Epidemiol       Date:  2003-09-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.